Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer

Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer

This item appears in the following Collection(s)

Available in accordance with the IUPUI Open Access Policy.

Search Repository


My Account

Statistics